Results

Total Results: 162 records

Showing results for "prostate cancer screening".
Users also searched for: psa

  1. effectivehealthcare.ahrq.gov/sites/default/files/pdf/weight-gain-prevention_research-protocol.pdf
    January 01, 2020 - Title screening: Each title will be screened by 2 independent reviewers for potential relevance to … Abstract screening: Each abstract will be reviewed by 2 independent reviewers. … Weight gain is associated with an increased risk of prostate cancer recurrence after prostatectomy in … Effect of obesity on prostate-specific antigen recurrence after radiation therapy for localized prostatecancer as measured by the 2006 Radiation Therapy Oncology Group-American Society for Therapeutic
  2. effectivehealthcare.ahrq.gov/sites/default/files/pdf/methodological-recommendations-framework-communications_research.pdf
    September 01, 2013 - For example, the National Comprehensive Cancer Network guidelines for breast cancer screening, or prostatecancer screening and management referred primarily to health care systems in developed economies and … NCCN clinical practice guidelines in oncology: prostate cancer early detection. … NCCN clinical practice guidelines in oncology: prostate cancer. … Modification and implementation of NCCN guidelines on prostate cancer in the Middle East and North
  3. effectivehealthcare.ahrq.gov/sites/default/files/related_files/patient-clinician-level-strategies-draft-tech-brief.pdf
    February 01, 2023 - Brief report of a tablet-delivered psychosocial intervention for men with advanced prostate cancer: … Intervention to Improve Awareness, Knowledge, and Utilization of Breast, Cervical, and Colorectal Cancer Screenings … The Effectiveness of Shared Compared to Informed Decision Making for Prostate Cancer Screening in a … Effects of a randomized trial comparing standard and enhanced counseling for men at high risk of prostatecancer as a function of race and monitoring style.
  4. effectivehealthcare.ahrq.gov/sites/default/files/pdf/chronic-urinary-retention_research.pdf
    September 01, 2014 - search identified 1,521 citations, of which 38 required full-text review after title and abstract screening … requiring an indwelling catheter or clean intermittent catheterization for at least 1 month before screening … Exclusion criteria: clinical evidence of prostate cancer, infection, previous prostatic surgery, uncontrolled … Exclusion criteria: Clinically diagnosed prostate cancer, previous prostatic surgery, life expectancy … and Symptoms of Overactive Bladder (Urge, Frequency) Device: Interstim therapy NCT01130415 Screening
  5. effectivehealthcare.ahrq.gov/products/cancer-end-of-life-quality-meaures/research
    May 17, 2010 - Seniors with breast, colorectal, lung, or prostate cancer who participated in state pharmaceutical benefit … cancer who died during the study period. … Health Organization. 37 The Joint Commission on Accreditation of Healthcare Organizations requires screeningcancer Earle et al. … cancer."
  6. effectivehealthcare.ahrq.gov/products/vitamin-d-calcium/research-protocol
    June 10, 2013 - Study-specific combinations of cardiovascular events Cancer (incident or mortality) Total cancer Prostatecancer Colorectal cancer Breast cancer Pancreatic cancer Cancer-specific mortality Immune … will be entered into the DistillerSR database (Evidence Partners, Inc., Ottawa, Ontario, Canada) for screening … After practice screening of a random selection of 100 titles, titles and abstracts will be dually screened
  7. effectivehealthcare.ahrq.gov/sites/default/files/pdf/horizon-scan_research-2015.pdf
    January 01, 2015 - with mammography screening. … Enzalutamide (Xtandi) for Treatment of Metastatic Castration-Resistant Prostate Cancer Enzalutamide … For the high end, we estimated that 35% of patients with advanced prostate cancer with symptoms related … cancer in the United States. … to screening.
  8. effectivehealthcare.ahrq.gov/sites/default/files/related_files/tech-brief-patient-provider-strategies-protocol-final.pdf
    May 18, 2022 - Interventions to Reduce Healthcare Disparities in Cancer Screening Among Minority Adults: a Systematic … Effectiveness of Patient Navigation to Increase Cancer Screening in Populations Adversely Affected by … Decision-making support among racial and ethnic minorities diagnosed with breast or prostate cancer: … Effectiveness of Patient Navigation to Increase Cancer Screening in Populations Adversely Affected by … Decision-making support among racial and ethnic minorities diagnosed with breast or prostate cancer:
  9. effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-quality-indicator-testing_research.pdf
    April 01, 2010 - One included indicator (for pain screening) was split into 2 indicators (inpatient and outpatient). … Routine symptom screening and recording could improve capacity to evaluate outcomes. … necessary to identify eligible patients often not well documented IF a cancer patient has a positive screening … settings Pain If a cancer patient has a cancer-related outpatient visit then there should be screening … pain using a numeric pain score IF a cancer patient is admitted to a hospital then there should be screening
  10. effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-end-of-life-quality-meaures_research.pdf
    April 01, 2010 - Seniors with breast, colorectal, lung, or prostate cancer who participated in state pharmaceutical benefit … cancer who died during the study period. … Health Organization.37 The Joint Commission on Accreditation of Healthcare Organizations requires screeningcancer Earle et al. … cancer.”
  11. effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-topics_methods.pdf
    July 01, 2012 - may fail to specify the patients who may benefit from the test—so that the test’s use ranges from a screening … Similarly, the request for a review of tests for prostate cancer may neglect to consider the role of … Harris and colleagues have described the value of the analytic framework in assessing screening tests … Full-Field Digital Mammography HER2 PET General topic FFDM to replace SFM in breast cancer screening … Refined claim In screening for breast cancer, interpretation of FFDM and SFM would be similar, leading
  12. effectivehealthcare.ahrq.gov/sites/default/files/pdf/vitamin-d-calcium_research-protocol.pdf
    September 13, 2013 - Study-specific combinations of cardiovascular events o Cancer (incident or mortality)  Total cancer  Prostatecancer  Colorectal cancer  Breast cancer  Pancreatic cancer  Cancer-specific mortality o … will be entered into the DistillerSR database (Evidence Partners, Inc., Ottawa, Ontario, Canada) for screening … After practice screening of a random selection of 100 titles, titles and abstracts will be dually screened
  13. effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-ovarian-contraceptives_research-protocol.pdf
    March 13, 2012 - If this is the case, screening, which is more likely to identify slower growing tumors, may have only … Ovarian cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial … Screening for ovarian cancer: a pilot randomised controlled trial. … Screening for ovarian cancer. Vol. 2010. … Reducing ovarian cancer mortality through screening: Is it possible, and can we afford it?
  14. effectivehealthcare.ahrq.gov/sites/default/files/pdf/rapid-assessment-research-updates_research.pdf
    September 15, 2008 - Comparative Effectiveness of Therapies for Clinically Localized Prostate Cancer 02/2008 14. … Osteoporosis 35 4 0 0 No Yes Comparative Effectiveness of Therapies for Clinically Localized ProstateCancer 10 7 3 0 No No Table 3. … Psoriatic Arthritis in Adults • Comparative Effectiveness of Therapies for Clinically Localized ProstateCancer 12 Low Priority • Comparative Effectiveness of Second-Generation Antidepressants in the
  15. effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-future-presentation-format_research.pdf
    January 01, 2019 - Of those, 167 were excluded after full text screening and 66 studies, reporting on 72 independent … in combination with prednisone or prednisolone for the treatment of hormone-refractory metastatic prostatecancer 2007 Health Technol Assess 17579936 Value of information analysis for a new technology: … of an analytic framework to inform resource allocation decisions in metastatic hormone-refractory prostatecancer 2009 Value Health 19558190 Informing disinvestment through cost-effectiveness modelling:
  16. effectivehealthcare.ahrq.gov/sites/default/files/related_files/vitamin-d-calcium_disposition-comments.pdf
    September 15, 2014 - organization. 5 Peer Reviewer 1 Executive Summary (Page 21) and elsewhere throughout the Report: ‘Prostatecancer’….higher serum vitamin D concentrations. … cancer. … cancer. … Screening recommendations are under the purview of the USPSTF.
  17. effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/epc-year-in-review-2021.pdf
    January 01, 2021 - Osteoporosis Prevention, Screening, and Diagnosis https://bit.ly/373w7LX Long-Term Drug Therapy and … Practice, clinician, and patient factors associated with the adoption of lung cancer screening. … evaluating external-beam radiotherapy with or without low-dose-rate brachytherapy boost for localized prostatecancer. … Patient-reported financial toxicity associated with contemporary treatment for localized prostate cancer
  18. effectivehealthcare.ahrq.gov/products/colon-cancer-gene-profiling/research-protocol
    March 13, 2012 - Systematic Review Tool (Evidence Partners Inc., Manotick, ON, Canada) will be used to facilitate the screening
  19. effectivehealthcare.ahrq.gov/sites/default/files/pdf/multinational-registries-guide-3rd-ed-addendum-white-paper.pdf
    February 01, 2018 - cancer (16.8 in Romania vs. 59.5 in the Czech Republic), stomach cancer (11.2 in the Czech Republic … Differences in diagnostic criteria and/or screening rates across countries can result in significant … For example, countries that do not implement standard breast or prostate cancer screening procedures … cancer often manifests with bone metastases, which are extremely painful and require expensive surgical … Combined with differences in national guidelines, policies, and regulations (e.g., recommended screening
  20. effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/multinational-registries-guide-3rd-ed-addendum-white-paper.pdf
    February 01, 2018 - cancer (16.8 in Romania vs. 59.5 in the Czech Republic), stomach cancer (11.2 in the Czech Republic … Differences in diagnostic criteria and/or screening rates across countries can result in significant … For example, countries that do not implement standard breast or prostate cancer screening procedures … cancer often manifests with bone metastases, which are extremely painful and require expensive surgical … Combined with differences in national guidelines, policies, and regulations (e.g., recommended screening

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: